Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior

NCT01495195 is registered in ClinicalTrials.gov with Midwest Biomedical Research as lead sponsor.

NCT NCT01495195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01495195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
Lead sponsor
Midwest Biomedical Research
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2012
Completion date
May 31, 2013
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine use disorders